Article
A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Oncogene - 8 Apr 2004
Adriaenssens Eric, Mougel Alexandra, Goormachtigh Gautier, Loing Estelle, Fafeur Véronique, Auriault Claude, Coll Jean
Abstract excerpt
The latent membrane protein-1 (LMP1) is an integral membrane molecule expressed by Epstein-Barr virus (EBV) during viral latency and displays properties of a constitutively activated member of the TNF receptor family. LMP1 is required for B-cell or monocyte immortalization induced by EBV and is sufficient to transform rodent fibroblasts. Transforming potential of LMP1 is mediated by its cytoplasmic C-terminal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
